Retina Gallery ~ Full Sized Retina Images

Myopic CNVM - lacquer crack - recurrence 6 years later 31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 175 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 221 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 198 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 178 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 211 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 196 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 203 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 202 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 200 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 200 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 169 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 165 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 187 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 171 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 186 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 189 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 195 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 199 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 228 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 209 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 218 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 180 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 223 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 197 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 160 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 172 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 185 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 194 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 173 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 185 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 173 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 192 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 182 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 198 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 217 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 188 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 191 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 185 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 223 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 201 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
40 photos sur 1 page(s)

31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.